Dr. Kathy Crew's work in breast cancer risk, prevention, and screening has been instrumental in the advancement of breast cancer research. In this Q+A, she discusses where we are in treatment, in research, and the challenges that lie ahead.
An annual tradition of the fall season is Velocity: Columbia’s Ride to End Cancer. This year, in response to COVID-19, Velocity is taking a new, personal approach called Your Velocity(link is external and opens in a new window).
Michael Shen, PhD, is a leading expert in prostate cancer and bladder cancer research. His ongoing work with three-dimensional cultures--organoids--to study prostate and bladder cancer could contribute to the development of new therapies and uncover key new insights to the molecular mechanisms responsible for tumor evolution and drug response.
A novel, emerging technique, called FLASH radiotherapy, has the potential to drastically shorten radiation treatment for cancer patients. A team of researchers at Columbia and the HICCC are dedicated to uncovering the underlying mechanisms behind this new, potentially life-changing cancer therapeutic.
Meet Calvin Martin, a member of the Community Advisory Board at the Herbert Irving Comprehensive Cancer Center. Calvin is a prostate cancer survivor and patient advocate who shares his own cancer story to raise awareness about the importance of routine screenings and to quell misconceptions of the disease.